PLoS ONE · 2015 · 27 citations · 33 references
MedicineCardiologyClinical CardiologyHemodynamic ManagementInterventional CardiologyAcute Coronary Syndrome InterventionAcute Coronary SyndromesIschemic Heart DiseaseMyocardial Blood Flow QuantificationAcute Coronary Syndrome ManagementAnimal Disease ModelsCardiac Outcome AssessmentHeart RateInfarct ExpansionInfarct Size AssessmentInfarct Size QuantificationMagnetic Resonance
BACKGROUND: Previous studies evaluating the progression of the necrotic wave in relation to heart rate were carried out only in animal models of ST-elevated myocardial infarction (STEMI). Aim of the study was to investigate changes of myocardial salvage in relation to different heart rates at hospital admission in timely reperfused patients with STEMI by using cardiovascular magnetic resonance (CMR). METHODS: One hundred-eighty-seven patients with STEMI successfully and timely treated with primary coronary angioplasty underwent CMR five days after hospital admission. According to the heart rate at presentation, patients were subcategorized into 5 quintiles: <55 bpm (group I, n = 44), 55-64 bpm (group II, n = 35), 65-74 bpm (group III, n = 35), 75-84 bpm (group IV, n = 37), ≥85 bpm (group V, n = 36). Area at risk, infarct size, microvascular obstruction (MVO) and myocardium salvaged index (MSI) were assessed by CMR using standard sequences. RESULTS: Lower heart rates at presentation were associated with a bigger amount of myocardial salvage after reperfusion. MSI progressively decreased as the heart rates increased (0.54 group I, 0.46 group II, 0.38 group III, 0.34 group IV, 0.32 group V, p<0.001). Stepwise multivariable analysis showed heart rate, peak troponin and the presence of MVO were independent predictor of myocardial salvage. No changes related to heart rate were observed in relation to area at risk and infarct size. CONCLUSIONS: High heart rates registered before performing coronary angioplasty in timely reperfused patients with STEMI are associated with a reduction in salvaged myocardium. In particular, salvaged myocardium significantly reduced when heart rate at presentation is ≥85 bpm.
33
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg, Michel Komajda, Michael Böhm et al. · The Lancet · 2010 · 2.6K citations · Full text
Medicine, Cardiology, Pharmacology +11
Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions
Peter R. Maroko, John Kjekshus, Burton E. Sobel et al. · Circulation · 1971 · 1.5K citations
Heart rate and cardiovascular mortality: The Framingham study
William B. Kannel, Craig Kannel, Ralph S. Paffenbarger et al. · American Heart Journal · 1987 · 1.3K citations